Health Care & Life Sciences » Pharmaceuticals | Ilsung Pharmaceutical Co. Ltd.

Ilsung Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
62,807
62,829
61,745
67,463
67,043
61,653
Cost of Goods Sold (COGS) incl. D&A
42,355
42,004
40,240
42,966
41,308
39,679
Gross Income
20,452
20,825
21,505
24,497
25,735
21,974
SG&A Expense
19,080
18,394
18,916
22,043
23,145
19,715
EBIT
1,372
2,431
2,590
2,454
2,590
2,258
Unusual Expense
742
118
228
49
67
699
Non Operating Income/Expense
8,424
2,753
126,537
616
10
895
Interest Expense
-
22
-
-
-
-
Pretax Income
10,976
7,907
131,019
4,987
4,582
4,587
Income Tax
3,021
3,872
32,165
1,970
1,954
1,641
Consolidated Net Income
7,955
4,035
98,854
3,017
2,629
2,946
Net Income
7,955
4,035
98,854
3,017
2,629
2,946
Net Income After Extraordinaries
7,955
4,035
98,854
3,017
2,629
2,946
Net Income Available to Common
7,955
4,035
98,854
3,017
2,629
2,946
EPS (Basic)
5,877.00
3,002.00
73,565.00
2,245.00
1,956.00
2,192
Basic Shares Outstanding
1
1
1
1
1
1
EPS (Diluted)
5,876.93
3,002.43
73,564.73
2,245.36
1,956.18
2,191.99
Diluted Shares Outstanding
1
1
1
1
1
1
EBITDA
4,574
5,242
5,351
5,476
5,818
5,272
Non-Operating Interest Income
1,943
2,606
2,121
1,868
1,935
734

About Ilsung Pharmaceutical Co.

View Profile
Address
9 Wonhyo-ro 84-gil
Seoul SL 04315
Korea, Republic Of
Employees -
Website http://www.ilsung-ph.co.kr
Updated 07/08/2019
Ilsung Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its products include contrast media, patches, antibiotics, antiviral agents, dermatologic agents, cardiovascular agents, antidiabetic agents, analgesics, muscle relaxants, neuropsychiatric agents, antitussives and expectorants. The company was founded by Yoon Byung-Kang in 1954 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.